Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.

Bill Information - History

House Bill 1741; Regular Session 2021-2022

Text

[History]

[Votes]

Sponsors:

KEEFER, COX, RYAN, KAUFFMAN, HERSHEY, BERNSTINE, ZIMMERMAN, ROWE, JONES, TWARDZIK, RAPP, BOROWICZ, DIAMOND, GREINER, GILLEN, MALONEY, HAMM and STAATS

Printer's No.(PN):

3241*, 2713, 1972

Short Title:

An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.

Actions:

	PN 1972	Referred to HEALTH, July 30, 2021
	PN 2713	Reported as amended, Feb. 7, 2022
		First consideration, Feb. 7, 2022
		Laid on the table, Feb. 7, 2022
		Removed from table, June 7, 2022
		Laid on the table, June 7, 2022
		Removed from table, June 8, 2022
	PN 3241	Second consideration, with amendments, June 14, 2022
		Re-committed to APPROPRIATIONS, June 14, 2022
		(Remarks see House Journal Page 591-594), June 14, 2022

* denotes current Printer's Number

How to Read a Bill About PDF Documents